Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Total debt minus cash and cash equivalents
Latest
$-98.50M
↓ 54% vs avg
Percentile
P38
Within normal range
Streak
1 yr
Consecutive growthCompressed
Average
$-64.06M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-98.50M | +20.6% |
| 2024 | $-124.12M | -24.4% |
| 2023 | $-99.81M | -32.7% |
| 2022 | $-75.21M | +31.5% |
| 2021 | $-109.86M | -130.3% |
| 2020 | $-47.70M | -866.3% |
| 2019 | $-4.94M | +33.1% |
| 2018 | $-7.38M | +18.1% |
| 2017 | $-9.01M | - |